732 related articles for article (PubMed ID: 21965636)
61. Efficacy and safety of mirtazapine in fibromyalgia syndrome patients: a randomized placebo-controlled pilot study.
Yeephu S; Suthisisang C; Suttiruksa S; Prateepavanich P; Limampai P; Russell IJ
Ann Pharmacother; 2013; 47(7-8):921-32. PubMed ID: 23737510
[TBL] [Abstract][Full Text] [Related]
62. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R
Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Distler O; Eich W; Dokoupilova E; Dvorak Z; Fleck M; Gaubitz M; Hechler M; Jansen JP; Krause A; Bendszus M; Pache L; Reiter R; Müller-Ladner U
Arthritis Rheum; 2010 Jan; 62(1):291-300. PubMed ID: 20039417
[TBL] [Abstract][Full Text] [Related]
64. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
65. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
[TBL] [Abstract][Full Text] [Related]
66. Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change.
Byon W; Ouellet D; Chew M; Ito K; Burger P; Pauer L; Zeiher B; Corrigan B
J Clin Pharmacol; 2010 Jul; 50(7):803-15. PubMed ID: 20357295
[TBL] [Abstract][Full Text] [Related]
67. Fibromyalgia: poorly understood; treatments are disappointing.
Prescrire Int; 2009 Aug; 18(102):169-73. PubMed ID: 19746561
[TBL] [Abstract][Full Text] [Related]
68. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia.
Arnold LM; Crofford LJ; Martin SA; Young JP; Sharma U
Pain Med; 2007; 8(8):633-8. PubMed ID: 18028041
[TBL] [Abstract][Full Text] [Related]
69. Efficacy and safety of pregabalin in patients with spinal cord injury: a pooled analysis.
Parsons B; Sanin L; Yang R; Emir B; Juhn M
Curr Med Res Opin; 2013 Dec; 29(12):1675-83. PubMed ID: 23998397
[TBL] [Abstract][Full Text] [Related]
70. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
[TBL] [Abstract][Full Text] [Related]
71. Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy.
de Haas S; Otte A; de Weerd A; van Erp G; Cohen A; van Gerven J
J Clin Sleep Med; 2007 Aug; 3(5):473-8. PubMed ID: 17803010
[TBL] [Abstract][Full Text] [Related]
72. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.
Simpson DM; Schifitto G; Clifford DB; Murphy TK; Durso-De Cruz E; Glue P; Whalen E; Emir B; Scott GN; Freeman R;
Neurology; 2010 Feb; 74(5):413-20. PubMed ID: 20124207
[TBL] [Abstract][Full Text] [Related]
73. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief.
Stacey BR; Barrett JA; Whalen E; Phillips KF; Rowbotham MC
J Pain; 2008 Nov; 9(11):1006-17. PubMed ID: 18640074
[TBL] [Abstract][Full Text] [Related]
74. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
Arnold LM; Palmer RH; Gendreau RM; Chen W
Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218
[TBL] [Abstract][Full Text] [Related]
75. Pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy: a randomized withdrawal trial.
Raskin P; Huffman C; Toth C; Asmus MJ; Messig M; Sanchez RJ; Pauer L
Clin J Pain; 2014 May; 30(5):379-90. PubMed ID: 23887339
[TBL] [Abstract][Full Text] [Related]
76. α1-Antitrypsin in fibromyalgia: results of a randomized, placebo-controlled, double-blind and crossover pilot trial.
Alegre C; Barceló M; Jardí R; Rodríguez-Frias F; Camprubí S
Musculoskeletal Care; 2012 Sep; 10(3):178-83. PubMed ID: 22190533
[TBL] [Abstract][Full Text] [Related]
77. Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.
Vinik A; Emir B; Parsons B; Cheung R
Pain Med; 2014 Apr; 15(4):661-70. PubMed ID: 24330406
[TBL] [Abstract][Full Text] [Related]
78. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
[TBL] [Abstract][Full Text] [Related]
79. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
Sang CN; Sathyanarayana R; Sweeney M;
Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
[TBL] [Abstract][Full Text] [Related]
80. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
Backonja MM; Canafax DM; Cundy KC
Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
